Full Text
A real-world economic analysis of the cost implications of switching from sevelamer hydrochloride to lanthanum carbonate in the bundled reimbursement scheme

Abstract

Authors

M.S. Keith R.J. Wilson J.B. Copley

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×